SEC EDGAR Filing Information

Form 3/A -- Initial statement of beneficial ownership of securities [amend]

Period of Report: 2006-08-29
Filing Date Changed: 2007-08-14
Documents: 1

SEC Accession No.
0001140361-07-016383
Filing date: 2007-08-14
Accepted: 2007-08-14 16:27:49

Table of submitted documents:

Seq	Type	Document	Size	Description
1	3/A	doc1.html		FORM 3/A
1	3/A	doc1.xml	3620	FORM 3/A

		0001140361-07-016383.txt	5849	Complete submission text file

Filer Information:

DOR BIOPHARMA INC (Issuer) (0000812796)
IRS No.: 411505029 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Assistant Director 1

Business Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131
305-534-3383

Mailing Address
1101 BRICKELL AVENUE
SUITE 701 S
MIAMI FL 33131

SCHABER CHRISTOPHER J (Reporting) (0001068029)
Type: 3/A | Act: 34 | File No.: 000-16929 | Film No.: 071055641

Business Address
C/O DISCOVERY LABORATORIES INC
3359 DURHAM ROAD
DOYLESTOWN PA 18901
305-534-3383

Mailing Address
1101 BRICKELL AVE
#701 S
MIAMI FL 33131